Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
about
Treatment of neurological injury with thymosin β4High-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Functional Recovery by Enhancing Neurogenesis and Activating BDNF/TrkB Signaling in Ischemic Rats.Traumatic white matter injury and glial activation: from basic science to clinics.Thymosin β4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathwayA dose-response study of thymosin β4 for the treatment of acute stroke.Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic miceMethod parameters' impact on mortality and variability in rat stroke experiments: a meta-analysis.Granulocyte-macrophage colony-stimulating factor-transfected bone marrow stromal cells for the treatment of ischemic strokeTherapeutic Benefit of Extended Thymosin β4 Treatment Is Independent of Blood Glucose Level in Mice with Diabetic Peripheral Neuropathy.Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats.Effects of Tetramethylpyrazine on Functional Recovery and Neuronal Dendritic Plasticity after Experimental Stroke.Thymosin β4 overexpression regulates neuron production and spatial distribution in the developing avian optic tectum.Thymosin β 4 mediates oligodendrocyte differentiation by upregulating p38 MAPK.Strategies targeting endogenous neurogenic cell response to improve recovery following traumatic brain injury.A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing.Oligodendrogenesis after cerebral ischemia.A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke.Neurorestorative treatments for traumatic brain injuryThymosin β4 sustained release from poly(lactide-co-glycolide) microspheres: synthesis and implications for treatment of myocardial ischemia.Distal occlusion of the middle cerebral artery in mice: are we ready to assess long-term functional outcome?Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.Rodent Gymnastics: Neurobehavioral Assays in Ischemic Stroke.Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model.Electromagnetic Fields for the Regulation of Neural Stem Cells.Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats.Erythropoietin mediates neurobehavioral recovery and neurovascular remodeling following traumatic brain injury in rats by increasing expression of vascular endothelial growth factor.Neuroprotective and neurorestorative effects of thymosin β4 treatment following experimental traumatic brain injury.Thymosin beta 4 up-regulates miR-200a expression and induces differentiation and survival of rat brain progenitor cells.Thymosin β4 and tissue transglutaminase. Molecular characterization of cyclic thymosin β4.Thymosin β4 as a restorative/regenerative therapy for neurological injury and neurodegenerative diseases.Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic/ischemic brains.Thymosin β4 for the treatment of acute stroke in aged rats.Thymosin β4 Deficiency Exacerbates Renal and Cardiac Injury in Angiotensin-II-Induced Hypertension.Thymosin β4 significantly reduces the signs of dryness in a murine controlled adverse environment model of experimental dry eye.RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
P2860
Q27006210-00F3489D-4050-4583-A613-261D631EFB4CQ30360887-335DCC29-F9BF-4068-81A9-796EEDB5DFECQ30816308-B967C861-47B3-4C94-A852-BEE6A548B321Q33888545-FABD776A-7DF3-4A4B-8CA1-0842A8AA09BAQ34257574-7F1C2016-A2E3-49AC-9105-1AF3E5CC67FEQ34393516-35A1179A-C96A-4450-97EF-780DC325FAB1Q34645508-A4E787E2-9F48-404A-9671-E4E9B2ACF0A9Q35109275-46A86D9C-03EF-4259-A819-3130D06DBF7EQ35511977-D5B93B7A-D1A2-4A53-B8F7-5C098554B851Q35691434-92AC12CB-98BD-4C6B-9FEE-322B832C8A10Q36038352-5CCB971F-2029-4611-8308-E60FE4837746Q36220357-C595D3E7-F93A-40C4-8907-A99F81182EFAQ36855028-9ECD5EA4-9332-4AA4-88C6-42961BF58089Q36909283-A7847902-65AC-4990-B6C4-4823BC21ECD2Q37221061-D312F515-D822-4B2B-9DD9-D4D01CBBA732Q37261533-64785D88-0C9B-4D7E-ACED-3A2A9CDD4387Q37449324-CC0699DD-49E2-48B9-90CD-ABCA2F9FBA5FQ37814534-5C67C966-E976-4DFA-B4C2-EDDC38CE10B9Q38050840-E5DA0EE1-82BD-4C38-95FC-BAA504DC278EQ38169992-106233CC-147D-43C4-9386-00BFECF6B216Q38538932-92B51EE9-BBD2-4B3A-B535-BB6C50253724Q38983613-3352E787-C3A2-4925-8E0B-8253AF4DF926Q39188067-81DE1D13-5302-415A-A10F-A0D36CB77628Q41432542-113CE22B-7158-44FD-B37F-17CFA6D0094EQ41832205-68E24E8C-8C03-47A6-A697-406BCDB2E83EQ42200726-CF8953FB-B058-48EB-A71A-7C8773C750D8Q42775909-ADF045D5-4B1C-40EB-B61E-2260D8211571Q43119647-3272D436-B912-4017-A605-67188D94E488Q47705887-88750C78-7AF8-4D1D-B9EA-39F95F3BC7F6Q48364529-D71AC4B9-467E-4AFC-B1B5-DF4649B8F062Q48595181-03D56112-CE51-4665-B953-C998ADA76480Q50232281-EE5DF3C8-E9A4-4D2A-9D35-962B4B2A1C7EQ52597899-3302001B-7235-4506-A98A-8D19DD394CC0Q53459932-0627233E-A3AB-4DAE-9D89-048E923BDF6CQ55618002-86A6743C-2B14-4B70-8031-90D285D19ABB
P2860
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
@ast
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
@en
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
@nl
type
label
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
@ast
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
@en
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
@nl
prefLabel
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
@ast
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
@en
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
@nl
P2093
P2860
P1433
P1476
Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.
@en
P2093
P2860
P304
P356
10.1016/J.NEUROSCIENCE.2010.05.017
P407
P577
2010-08-01T00:00:00Z